Download Files:
Products Details
Product Description
– EP4 receptor antagonist 3 is a potent EP4 receptor antagonist, example 3,extracted from patent WO2010019796 A1. EP4 receptor antagonist 3 can be used for the reseacrh of EP4 receptor-mediated diseases, such as acute and chronic pain, osteoarthritis, rheumatoid arthritis and cancer[1].
Web ID
– HY-138761
Shipping
– Room temperature
Applications
– COVID-19-immunoregulation
Molecular Formula
– C26H21F3N2O3S
References
– [1]Wei W. Yuan, et al. Heterocyclic amide derivatives as ep4 receptor antagonists. Patent WO2010019796A1.
CAS Number
– 1207954-34-4
Molecular Weight
– 498.52
SMILES
– O=C(O)C1=CC=C(C2(NC(C3=C(C)SC4=C3N(CC5=CC=C(C(F)(F)F)C=C5)C=C4)=O)CC2)C=C1
Clinical Information
– No Development Reported
Research Area
– Cancer; Inflammation/Immunology
Solubility
– 10 mM in DMSO
Target
– Prostaglandin Receptor
Isoform
– EP
Pathway
– GPCR/G Protein
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
